California Water Service Group Announces Nomination of Dr. Yvonne A. Maldonado for Election to Board of Directors
April 14, 2021 16:15 ET | Source: California Water Service Group California Water Service Group San Jose, California, UNITED STATES
SAN JOSE, Calif., April 14, 2021 (GLOBE NEWSWIRE) California Water Service Group (Group) (NYSE: CWT) announced today the nomination of Dr. Yvonne (Bonnie) A. Maldonado, 65, as an independent director for election to the company’s Board of Directors. The election will be held at Group’s 2021 Annual Meeting on May 26, 2021.
A pediatric infectious diseases epidemiologist and the Taube Professor of Global Health and Infectious Diseases at Stanford University School of Medicine, Maldonado is also the medical director of Infection Prevention and Control and an attending physician at Packard Children’s Hospital at Stanford. She is a professor in the Departments of Pediatrics and Heal
Stanford tests Pfizer vaccine on children 5 and younger
By KTVU staff
Stanford enrolls children in vaccine study
PALO ALTO, Calif. - New tests are underway at the Stanford School of Medicine on giving the Pfizer coronavirus vaccine to children 5 and younger.
Video provided by Stanford on Wednesday shows volunteers as young as 2 years old during phase one of this trial.
During the study, three doses of the vaccine will be tested for safety and how the children handle it.
Later this spring, there will be a larger study on children between 5 and 12 years old.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
California Water Service Group Announces Nomination of Dr. Yvonne A. Maldonado for Election to .
California Water Service GroupApril 14, 2021 GMT
SAN JOSE, Calif., April 14, 2021 (GLOBE NEWSWIRE) California Water Service Group (Group) (NYSE: CWT) announced today the nomination of Dr. Yvonne (Bonnie) A. Maldonado, 65, as an independent director for election to the company’s Board of Directors. The election will be held at Group’s 2021 Annual Meeting on May 26, 2021.
A pediatric infectious diseases epidemiologist and the Taube Professor of Global Health and Infectious Diseases at Stanford University School of Medicine, Maldonado is also the medical director of Infection Prevention and Control and an attending physician at Packard Children’s Hospital at Stanford. She is a professor in the Departments of Pediatrics and Health Research and Policy; chief of the Division of Infectiou
Share this article
Share this article
SALT LAKE CITY, April 13, 2021 /PRNewswire/ ARUP Laboratories today announced the retirement of CEO Sherrie L. Perkins, MD, PhD, effective June 30, 2021. ARUP also announced that Andy Theurer, currently ARUP s president, has been appointed by the company s Board of Directors to become CEO with Perkins retirement.
Tracy George, MD, will replace Theurer as president and will retain her current position as ARUP s chief medical officer (CMO). I am very grateful to Sherrie Perkins for her exceptional leadership as CEO and for her many other extraordinary contributions to ARUP and the University of Utah School of Medicine, said Peter E. Jensen, MD, chairman of the ARUP Board of Directors and of the U School of Medicine Department of Pathology. She has demonstrated a true commitment to ARUP and the work we do that has such an impact on patients and on our clients nationwide. She will be sorely missed.
Children will die : Transgender advocates warn about risks as more states consider banning gender-affirming care for kids Marc Ramirez, USA TODAY
Replay Video UP NEXT
Willow Breshears knew she was different for as long as she can remember. Growing up in rural Arkansas, she said she often felt depressed her personal discoveries about herself quashed by social norms and Baptist teachings.
Now 18 and living in Little Rock, the transgender activist recently testified before lawmakers as part of an effort to try to stop the passage of a proposed state law that, among other things, bans doctors from providing gender-affirming care such as including puberty blockers and hormone therapy to youth under 18. She and others protesting the measure were unsuccessful.